Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012:2012:750126.
doi: 10.1155/2012/750126. Epub 2011 Oct 13.

Targeting endothelial dysfunction in vascular complications associated with diabetes

Affiliations

Targeting endothelial dysfunction in vascular complications associated with diabetes

Arpeeta Sharma et al. Int J Vasc Med. 2012.

Abstract

Cardiovascular complications associated with diabetes remain a significant health issue in westernized societies. Overwhelming evidence from clinical and laboratory investigations have demonstrated that these cardiovascular complications are initiated by a dysfunctional vascular endothelium. Indeed, endothelial dysfunction is one of the key events that occur during diabetes, leading to the acceleration of cardiovascular mortality and morbidity. In a diabetic milieu, endothelial dysfunction occurs as a result of attenuated production of endothelial derived nitric oxide (EDNO) and augmented levels of reactive oxygen species (ROS). Thus, in this review, we discuss novel therapeutic targets that either upregulate EDNO production or increase antioxidant enzyme capacity in an effort to limit oxidative stress and restore endothelial function. In particular, endogenous signaling molecules that positively modulate EDNO synthesis and mimetics of endogenous antioxidant enzymes will be highlighted. Consequently, manipulation of these unique targets, either alone or in combination, may represent a novel strategy to confer vascular protection, with the ultimate goal of improved outcomes for diabetes-associated vascular complications.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Under basal conditions, eNOS is kept in a “less active” state by binding to Cav-1. Activation of eNOS occurs by stimuli, (sheer stress, agonists such as acetylcholine, Ach), which causes an increase in intracellular Ca2+ and subsequent recruitment of cofactors and phosphorylation of the enzyme at S1177. Following which, eNOS is dissociated from Cav-1 and efficient EDNO production occurs. CaM: calmodulin; hsp90: heat shock protein 90.
Figure 2
Figure 2
Pathways activated during hyperglycaemia that limit eNOS function and subsequent NO production, leading to endothelial dysfunction and diabetes-associated vascular disease.
Figure 3
Figure 3
Classic antioxidant pathways for the neutralization of ROS produced by hyperglycaemia in the cytoplasm and mitochondria of endothelial cells. O2 •−: superoxide anion; ONOO: peroxynitrite; NO2 : nitrite; H2O2: hydrogen peroxide; OH: hydroxyl radicals; LOOH: lipid hydroperoxides; LOH: lipid alcohol; Nox: NADPH oxidase.

References

    1. Dunstan DW, Zimmet PZ, Welborn TA, et al. The rising prevalence of diabetes and impaired glucose tolerance: the Australian diabetes, obesity and lifestyle study. Diabetes Care. 2002;25(5):829–834. - PubMed
    1. Narayan KMV, Boyle JP, Thompson TJ, Sorensen SW, Williamson DF. Lifetime risk for diabetes mellitus in the United States. JAMA. 2003;290(14):1884–1890. - PubMed
    1. Thompson D, Wolf AM. The medical-care cost burden of obesity. Obesity Reviews. 2001;2(3):189–197. - PubMed
    1. Lockhart CJ, Hamilton PK, McVeigh KA, McVeigh GE. A cardiologist view of vascular disease in diabetes. Diabetes, Obesity and Metabolism. 2008;10(4):279–292. - PubMed
    1. Grundy SM, Benjamin IJ, Burke GL, et al. Diabetes and cardiovascular disease: a statement for healthcare professionals from the american heart association. Circulation. 1999;100(10):1134–1146. - PubMed

LinkOut - more resources